Predict your next investment

HEALTHCARE | Biotechnology
arciontherapeutics.com

See what CB Insights has to offer

Executives

2

Board of Directors

1

Arcion Therapeutics Board of Director

1 Board of directors

Arcion Therapeutics has 1 board of directors, including Arnold Oronsky.

Name

Firm

Work History

Other Seats

Arnold Oronsky

Arnie Oronsky, Ph.D. is a founder and board member of Centrexion Therapeutics. Arnie currently serves as a general partner and managing director at InterWest Partners LLC, a venture capital firm. Earlier in his career, Arnie led pharmaceutical research as vice president for discovery research for the Lederle Laboratories division of American Cyanamid Company. He is a board member of Applied Genetic Technologies Corporation, Drais Pharmaceuticals, Dynavax Technologies, EpicentRx, Integrated Diagnostics, PMV Pharma, Potenza Therapeutics, Sera Prognostics, TESARO and Tizona Therapeutics. Arnie holds a B.A. degree from New York University, a Ph.D. in Immunology from Columbia University and is a senior lecturer at Johns Hopkins Medical School.

Arcion Therapeutics

Name

Arnold Oronsky

Firm

Work History

Arnie Oronsky, Ph.D. is a founder and board member of Centrexion Therapeutics. Arnie currently serves as a general partner and managing director at InterWest Partners LLC, a venture capital firm. Earlier in his career, Arnie led pharmaceutical research as vice president for discovery research for the Lederle Laboratories division of American Cyanamid Company. He is a board member of Applied Genetic Technologies Corporation, Drais Pharmaceuticals, Dynavax Technologies, EpicentRx, Integrated Diagnostics, PMV Pharma, Potenza Therapeutics, Sera Prognostics, TESARO and Tizona Therapeutics. Arnie holds a B.A. degree from New York University, a Ph.D. in Immunology from Columbia University and is a senior lecturer at Johns Hopkins Medical School.

Other Seats

Arcion Therapeutics

Arcion Therapeutics Management Team

2 Team Members

Arcion Therapeutics has 2 executives. Arcion Therapeutics's current Chief Executive Officer is James N Campbell.

Name

Work History

Title

Status

James N Campbell

Chief Executive Officer

Current

Kerrie L Brady

Chief Operating Officer

Former

Name

James N Campbell

Kerrie L Brady

Work History

Title

Chief Executive Officer

Chief Operating Officer

Status

Current

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.